Life and death of molecular subclones in recurrent meningioma: A case study.
Sign Up to like & getrecommendations! Published in 2022 at "Clinical neuropathology"
DOI: 10.5414/np301365
Abstract: Meningiomas are the most common primary intracranial tumors, of which atypical meningiomas account for ~ 20%. A loss of NF2 has been proven to be an initial step for meningioma development; however, the role of non-NF2… read more here.
Keywords: case; subclone; mutation; non nf2 ... See more keywords